JP2017129597A5 - - Google Patents

Download PDF

Info

Publication number
JP2017129597A5
JP2017129597A5 JP2017069908A JP2017069908A JP2017129597A5 JP 2017129597 A5 JP2017129597 A5 JP 2017129597A5 JP 2017069908 A JP2017069908 A JP 2017069908A JP 2017069908 A JP2017069908 A JP 2017069908A JP 2017129597 A5 JP2017129597 A5 JP 2017129597A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
interleukin
identity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017069908A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017129597A (ja
JP6798922B2 (ja
Filing date
Publication date
Priority claimed from KR1020110012983A external-priority patent/KR20120093002A/ko
Application filed filed Critical
Publication of JP2017129597A publication Critical patent/JP2017129597A/ja
Publication of JP2017129597A5 publication Critical patent/JP2017129597A5/ja
Application granted granted Critical
Publication of JP6798922B2 publication Critical patent/JP6798922B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017069908A 2011-02-14 2017-03-31 がんを診断する方法およびnk細胞活性の測定を使用した診断キット Active JP6798922B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110012983A KR20120093002A (ko) 2011-02-14 2011-02-14 Nk 세포의 활성 측정을 이용한 암 진단 방법 및 진단 키트
KR10-2011-0012983 2011-02-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013553044A Division JP6629497B2 (ja) 2011-02-14 2012-02-10 がんを診断する方法およびnk細胞活性の測定を使用した診断キット

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019126244A Division JP2019207242A (ja) 2011-02-14 2019-07-05 がんを診断する方法およびnk細胞活性の測定を使用した診断キット

Publications (3)

Publication Number Publication Date
JP2017129597A JP2017129597A (ja) 2017-07-27
JP2017129597A5 true JP2017129597A5 (enExample) 2017-09-07
JP6798922B2 JP6798922B2 (ja) 2020-12-09

Family

ID=46672988

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2013553044A Active JP6629497B2 (ja) 2011-02-14 2012-02-10 がんを診断する方法およびnk細胞活性の測定を使用した診断キット
JP2017069908A Active JP6798922B2 (ja) 2011-02-14 2017-03-31 がんを診断する方法およびnk細胞活性の測定を使用した診断キット
JP2019126244A Pending JP2019207242A (ja) 2011-02-14 2019-07-05 がんを診断する方法およびnk細胞活性の測定を使用した診断キット
JP2021197948A Withdrawn JP2022043119A (ja) 2011-02-14 2021-12-06 がんを診断する方法およびnk細胞活性の測定を使用した診断キット
JP2023076634A Active JP7660605B2 (ja) 2011-02-14 2023-05-08 がんを診断する方法およびnk細胞活性の測定を使用した診断キット

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013553044A Active JP6629497B2 (ja) 2011-02-14 2012-02-10 がんを診断する方法およびnk細胞活性の測定を使用した診断キット

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2019126244A Pending JP2019207242A (ja) 2011-02-14 2019-07-05 がんを診断する方法およびnk細胞活性の測定を使用した診断キット
JP2021197948A Withdrawn JP2022043119A (ja) 2011-02-14 2021-12-06 がんを診断する方法およびnk細胞活性の測定を使用した診断キット
JP2023076634A Active JP7660605B2 (ja) 2011-02-14 2023-05-08 がんを診断する方法およびnk細胞活性の測定を使用した診断キット

Country Status (20)

Country Link
US (2) US11442069B2 (enExample)
EP (1) EP2676139B1 (enExample)
JP (5) JP6629497B2 (enExample)
KR (3) KR20120093002A (enExample)
CN (1) CN103370622B (enExample)
AU (2) AU2012219184A1 (enExample)
BR (1) BR112013020454B1 (enExample)
CA (1) CA2826053C (enExample)
CL (1) CL2013002361A1 (enExample)
DK (1) DK2676139T3 (enExample)
EA (1) EA038959B1 (enExample)
ES (1) ES2797549T3 (enExample)
IL (1) IL227952B (enExample)
MX (1) MX361731B (enExample)
MY (1) MY175351A (enExample)
RU (1) RU2635194C2 (enExample)
SG (1) SG192247A1 (enExample)
TW (2) TWI668445B (enExample)
UA (1) UA120697C2 (enExample)
WO (1) WO2012110878A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120093002A (ko) 2011-02-14 2012-08-22 (주)에이티젠 Nk 세포의 활성 측정을 이용한 암 진단 방법 및 진단 키트
WO2015069187A1 (en) 2013-11-05 2015-05-14 Agency For Science, Technology And Research Bladder Carcinoma Biomarkers
JP6073417B2 (ja) * 2015-06-26 2017-02-01 チャ バイオテック カンパニー リミテッド 自然殺害細胞増殖方法、及び自然殺害細胞増殖用の組成物
KR101926166B1 (ko) * 2016-05-24 2018-12-06 재단법인 아산사회복지재단 수용체 시너지 활성을 이용한 nk 세포의 활성도 검사 방법 및 이를 이용한 nk 세포의 활성도가 관련된 질환의 진단 방법
WO2017204446A2 (ko) * 2016-05-24 2017-11-30 울산대학교 산학협력단 수용체 시너지 활성을 이용한 nk 세포의 활성도 검사 방법 및 이를 이용한 nk 세포의 활성도가 관련된 질환의 진단 방법
CN106222140A (zh) * 2016-08-04 2016-12-14 英普乐孚生物技术(上海)有限公司 一种nk细胞无血清培养基及其配制方法
CN107686828A (zh) * 2016-08-04 2018-02-13 英普乐孚生物技术(上海)有限公司 一种nk细胞无血清培养基
CN106085958A (zh) * 2016-08-04 2016-11-09 英普乐孚生物技术(上海)有限公司 一种nk细胞的制备方法
BR112019016374A2 (pt) 2017-02-17 2020-04-07 Bristol-Myers Squibb Company anticorpos para alfa-sinucleína e usos dos mesmos
US11629340B2 (en) 2017-03-03 2023-04-18 Obsidian Therapeutics, Inc. DHFR tunable protein regulation
KR102090698B1 (ko) * 2017-08-24 2020-04-23 연세대학교 산학협력단 암의 진단, 모니터링, 또는 예후 예측을 위해 생체 외 인터페론-감마의 양을 측정하는 방법
JP7268039B2 (ja) 2018-02-01 2023-05-02 エヌケーマックス カンパニー リミテッド がん治療のためのナチュラルキラー細胞および組成物の製造方法
EP3924368A4 (en) * 2019-02-14 2022-12-14 Research Institute at Nationwide Children's Hospital USE OF A STIMULATING AGENT TO ANALYZE THE POTENCY OF IMMUNE CELLS
WO2021041399A1 (en) * 2019-08-29 2021-03-04 Board Of Regents, The University Of Texas System Cell cryopreservation medium
CN112552391B (zh) * 2019-09-25 2024-08-23 北京志道生物科技有限公司 一种重组白介素-15类似物
CN114929249A (zh) * 2019-11-29 2022-08-19 Nkmax有限公司 产生自然杀伤细胞及其组合物的方法
WO2022024693A1 (ja) * 2020-07-29 2022-02-03 国立大学法人東北大学 シヌクレイノパチーを予防又は治療するために使用されるペプチド
CN113533729B (zh) * 2021-06-15 2024-09-06 北京大学人民医院 一种鉴定aml患者骨髓中nk细胞耗竭的研究方法及其应用
EP4448554A1 (en) * 2021-12-17 2024-10-23 University of Kent Sequences and methods for production of recombinant biological molecules in vesicles
KR20230156518A (ko) 2022-05-06 2023-11-14 (주)다이오진 엑소좀 내의 인터페론 감마 유전자 측정을 이용한 암 조기 진단 방법 및 진단 키트
CN115247149B (zh) * 2022-08-22 2023-06-16 华域生物科技(天津)有限公司 适用于nk细胞的培养基组合物及培养方法
CN115855779A (zh) * 2023-01-18 2023-03-28 山东康华生物医疗科技股份有限公司 一种定量检测nk细胞活性的磁微粒化学发光试剂盒及其检测方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2635088A (en) * 1987-12-04 1989-06-08 Du Pont Merck Pharmaceutical Company, The Immobilized interleukin 2 and interleukin 2 containing a carboxyl-terminal extension
HUT74425A (en) * 1993-08-09 1996-12-30 Baral A method for sensitization of cancer for killer cell mediated lysis
WO1996024369A1 (en) * 1995-02-06 1996-08-15 Genetics Institute, Inc. Formulations for il-12
US20060057651A1 (en) * 2000-12-08 2006-03-16 Bowdish Katherine S Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
US7781210B2 (en) 2001-08-13 2010-08-24 Junjiro Tsuchiyama Epstein-Barr virus-negative NK cell line
EP1451217A4 (en) * 2001-11-20 2005-10-12 Atgen Co Ltd NEW PEPTIDES PROVIDING ENVIRONMENTAL RESISTANCE, AND FUSION PROTEINS CONTAINING THOSE PEPTIDES
AU2003220557A1 (en) * 2002-03-26 2003-10-13 Centocor, Inc. Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses
JP2004305095A (ja) 2003-04-07 2004-11-04 Limuloid Science Kk 細胞活性化検出方法
CN1297567C (zh) * 2003-06-13 2007-01-31 马菁 具有抗肿瘤功能的双功能融合蛋白及其制备方法和应用
ATE500267T1 (de) * 2003-07-21 2011-03-15 Transgene Sa Multifunktionelle cytokine
WO2005013950A2 (en) 2003-08-08 2005-02-17 Avanir Pharmaceuticals Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
CA2542886A1 (en) 2003-11-05 2005-05-19 Neelima M. Bhat Enhanced b cell cytotoxicity of cdim binding antibody
KR100565764B1 (ko) * 2005-05-02 2006-03-28 (주)에이티젠 환경 스트레스에 내성을 부여하는 신규한 펩타이드 및 이를포함하는 융합 단백질
WO2005108423A1 (en) 2004-05-11 2005-11-17 Atgen Co., Ltd. Novel peptides conferring environmental stress resistance and fusion proteins including said peptides
JP4653465B2 (ja) 2004-10-25 2011-03-16 泰信 小林 ナチュラルキラー細胞の増殖促進方法およびそれに用いる培養組成物
EP1901766A2 (en) * 2005-04-08 2008-03-26 Morningside Venture Investments Limited Use of fril proteins for reducing the production of pro-inflammatory cytokines
WO2008013975A2 (en) * 2006-07-28 2008-01-31 The Research Foundation Of State University Of New York Methods and kits for measurement of lymphocyte function
WO2008070647A1 (en) * 2006-12-07 2008-06-12 Wyeth Methods and compositions for assessing il-12 or the neutralization of il-12 in a sample
CN101578113B (zh) 2007-01-11 2015-04-22 诺和诺德公司 抗-kir抗体、制剂及其应用
EP2048237A1 (en) * 2007-10-05 2009-04-15 Avir Green Hills Biotechnology Research Development Trade Ag Replication deficient Influenza virus for the expression of heterologous sequences
KR20120093002A (ko) 2011-02-14 2012-08-22 (주)에이티젠 Nk 세포의 활성 측정을 이용한 암 진단 방법 및 진단 키트

Similar Documents

Publication Publication Date Title
JP2017129597A5 (enExample)
Cameron et al. Cytokines, chemokines and their receptors
Xu et al. Interleukin-17 and its expanding biological functions
CN110913871B (zh) 生成哺乳动物t细胞活化诱导型合成启动子(syn+pro)以改善t细胞疗法
Akira The role of IL-18 in innate immunity
Pappu et al. The interleukin‐17 cytokine family: critical players in host defence and inflammatory diseases
Gaffen Biology of recently discovered cytokines: interleukin-17–a unique inflammatory cytokine with roles in bone biology and arthritis
Lazarevic et al. T-bet: a bridge between innate and adaptive immunity
CN112105633A (zh) 新型白介素2及其用途
JP2019207242A5 (enExample)
Giansanti et al. Avian cytokines-an overview
BRPI0707106B1 (pt) Polinucleotídeo interleucina-15, vetor de expressão, e, composição farmacêutica
HRP20200439T1 (hr) Onkolitički adenovirus koji kodira protein b7
RU2013141487A (ru) Способ диагностики злокачественной опухоли и набор для диагностики путем измерения активности nk-клеток
JP2017008109A5 (enExample)
Kim et al. Downregulation of chicken interleukin-17 receptor A during Eimeria infection
JP2019514373A5 (enExample)
EP3461844A3 (en) Improved amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
HRP20211113T1 (hr) Pripravci i metode za ciljanu dostavu citokina
JP2019506175A5 (enExample)
CN110050062A (zh) 表达il12的溶瘤弹状病毒
EA202190267A1 (ru) Способы и композиции с использованием рекомбинантных дендритных клеток для терапии рака
US20170327554A1 (en) Chemokine-cytokine fusion proteins and their applications
JP2005523681A5 (enExample)
CN103509814A (zh) 一种草鱼肿瘤坏死因子α基因的重组表达方法